Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode

Author:

Gillissen, B.; Richter, A.; Richter, A.; Overkamp, T.; Essmann, F.; Hemmati, P. G.; Preissner, R.; Belka, C.; Daniel, P. T.

Tübinger Autor(en):

Published in:

Cell Death & Disease (2013), Bd. 4, Article e643

Verlagsangabe:

Nature Publishing Group

Language:

English

Full text:

ISSN:

2041-4889

DDC Classifikation:

570 - Life sciences; biology
610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)